• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

International Alliance

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Topics Engaged In

  • Oh, bother! No topics were found here.

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition and Swallowing
  • Occupational Therapy and Activities of Daily Living
  • Physiotherapy and Mobility
  • Respiratory Care
  • Speech Therapy and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Events/Programs

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Newsletters
    • Meetings
  • Awards

Upcoming Events

Aug 19
8:00 am - 9:00 am EDT

Member Forum: Equitable Access to Care

Aug 19
6:00 pm - 7:00 pm EDT

Member Forum: Equitable Access to Care

Aug 20
11:00 am - 12:00 pm EDT

Les Turner ALS Foundation: ALS-FTD Clinicopathological Overlap

Sep 8
8:00 am - 9:00 am EDT

Member Forum: Health Literacy & Understanding ALS/MND

Sep 8
6:00 pm - 7:00 pm EDT

Member Forum: Health Literacy & Understanding ALS/MND

View Calendar

  • Susan Anderson, USA

    Susan Anderson, USA

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Ailsa Malcolm-Hutton, UK

    Ailsa Malcolm-Hutton, UK

  • Jan Zuring, Netherlands

    Jan Zuring, Netherlands

  • Ali Var, Turkey

    Ali Var, Turkey

  • Federica Mastrosimone, Italy

    Federica Mastrosimone, Italy

  • Calum Ferguson, Scotland

    Calum Ferguson, Scotland

  • Steve

    Steve

  • David Hall, USA

    David Hall, USA

  • Murat Morali, Turkey

    Murat Morali, Turkey

  • Stephanie Christiansen Hall, Canada

    Stephanie Christiansen Hall, Canada

  • Laurie Petit-Jean, France

    Laurie Petit-Jean, France

  • Glen Victor Peters, Australia

    Glen Victor Peters, Australia

  • Sébastien Batiot, France

    Sébastien Batiot, France

  • Antonio Ventriglia, Belgium

    Antonio Ventriglia, Belgium

  • Xian-Zhang Niu, China

    Xian-Zhang Niu, China

  • Ian Roberts, Australia

    Ian Roberts, Australia

  • David Watson, Scotland

    David Watson, Scotland

  • Jette Odgaard Villemoes, Denmark

    Jette Odgaard Villemoes, Denmark

  • Anna Barrow, UK

    Anna Barrow, UK

  • Dr. Shelly Hoover, USA

    Dr. Shelly Hoover, USA

  • Sanjay Kumar Srivastava, India

    Sanjay Kumar Srivastava, India

  • Len Johnrose, England

    Len Johnrose, England

  • Bayley, Australia

    Bayley, Australia

  • Cath Muir, UK

    Cath Muir, UK
    Cath

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Brian Lovell, Australia

    Brian Lovell, Australia

  • David Bishop, UK

    David Bishop, UK

  • Teddy Hanono Annie, Mexico

    Teddy Hanono Annie, Mexico

  • David Solomon, UK

    David Solomon, UK

  • Dorette Lüdi, Switzerland

    Dorette Lüdi, Switzerland

  • Manuel Arn, Switzerland

    Manuel Arn, Switzerland

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • João Marcos Andrietta, Brazil

    João Marcos Andrietta, Brazil

  • Alex, Argentina

    Alex, Argentina

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • Andrew Langat, Kenya

    Andrew Langat, Kenya

  • Norm MacIsaac, Canada

    Norm MacIsaac, Canada

  • Irene McCaughey, Australia

    Irene McCaughey, Australia

  • Den Haag, Netherlands

    Den Haag, Netherlands

  • Lineke Veenstra, Netherlands

    Lineke Veenstra, Netherlands

  • Liam Dwyer, England

    Liam Dwyer, England

  • Maurice LeClerc, Canada

    Maurice LeClerc, Canada

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Semra Gokalp, Turkey

    Semra Gokalp, Turkey

  • Cliff Marshman, USA

    Cliff Marshman, USA
    CliffMarshman

  • Purningam Jacob, India

    Purningam Jacob, India

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Mona H. Bahus and Camilla Knoff Glomstad, Norway

    Mona H. Bahus and Camilla Knoff Glomstad, Norway

  • Dawn Morton, Scotland

    Dawn Morton, Scotland

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login